| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 688329 | Null | 0.00295310816022625 | 0.21915021 |
| NSC 691577 | Null | 0.00295310816022625 | 0.35100792 |
| NSC 694000 | 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester | 0.00295310816022625 | -0.062597945 |
| NSC 702734 | Null | 0.00295310816022625 | 0.20912049 |
| NSC 710546 | Null | 0.00295310816022625 | 0.34431874 |
| NSC 724058 | 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.00295310816022625 | 0.30175415 |
| NSC 737225 | Null | 0.00295310816022625 | 0.270959 |
| NSC 747556 | 6-(4'-Hydroxy-2'-methylphenyl)-2-benzenesulfonamide-4,5-dihydropyridazine-3(2H)-one | 0.00295310816022625 | 0.21326484 |
| NSC 747558 | 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one | 0.00295310816022625 | 0.28071281 |
| NSC 756134 | GSK1023156A | 0.00295310816022625 | 0.20426121 |